First on CNN: HHS awards more than $500 million to study Covid-19 vaccine nasal sprays and more | CNN
www.cnn.com
In the future, some Covid-19 vaccines may not be jabs in the arm. They could be a nasal spray or even a patch on the skin. Those are just two examples of the kind of next-generation vaccine technology that federal health officials are hoping to help advance.

In the future, some Covid-19 vaccines may not be jabs in the arm. They could be a nasal spray or even a patch on the skin. Those are just two examples of the kind of next-generation vaccine technology that federal health officials are hoping to help advance.

The US Department of Health and Human Services announced Friday that it has selected three initial next-generation vaccine candidates to receive funding awards to help kick-start planning for Phase 2b clinical trials, slated to begin as early as this winter. Two of those studies involve intranasal vaccine candidates, and one involves a self-amplifying mRNA vaccine candidate.

HHS announced more than $500 million in awards to help advance the development of potential vaccines and therapeutics, which includes those initial three vaccine candidates.

  • Poutinetown
    1·
    9 months ago

    Will those easily work for other vaccines? Or would it need a separate trial for each type?

    • Dr. Bluefall@toast.oooEnglish
      3·
      9 months ago

      From the article:

      “While this is focused on Covid – and it should be as we look at this very unpredictable virus and try to stay ahead of it and try to get more durable and lasting immunity – the technology that we’re currently investing in, and are going to be announcing investments in, will be important in lots of different ways,” she added. “The ways in which we’re moving the science forward will be critical for future outbreaks of other diseases.”

      To me, this says that effectiveness against Covid-19 would be a proof-of-concept for the technology. If it works there, maybe it’ll also work for other diseases.